UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 152

Sortiert nach

Induction of Ovalbumin-Specific Tolerance by Oral Administration of Lactococcus lactis Secreting Ovalbumin

Gastroenterology (New York, N.Y. 1943), 2007-08, Vol.133 (2), p.517-528

2007

Volltextzugriff (PDF)

The Sphingosine‐1‐Phosphate Receptor Agonist FTY720 Modulates Dendritic Cell Trafficking In Vivo

American journal of transplantation, 2005-11, Vol.5 (11), p.2649-2659

2005

Volltextzugriff (PDF)

Developmental and Functional Defects of Thymic and Epidermal Vγ3 Cells in IL-15-Deficient and IFN Regulatory Factor-1-Deficient Mice

The Journal of immunology (1950), 2002-06, Vol.168 (12), p.6486-6493

2002

Volltextzugriff (PDF)

FRI-380 HBV-specific T cell specificity and functionality can be influenced by stage of chronic HBV disease, antigen levels and age

Journal of hepatology, 2024-06, Vol.80, p.S768-S768

2024

Volltextzugriff (PDF)

Expression of Inhibitory Receptors Ly49E and CD94/NKG2 on Fetal Thymic and Adult Epidermal TCR Vγ3 Lymphocytes

The Journal of immunology (1950), 2002-04, Vol.168 (7), p.3295-3302

2002

Volltextzugriff (PDF)

Expression of Ly49E and CD94/NKG2 on Fetal and Adult NK Cells

The Journal of immunology (1950), 2001-04, Vol.166 (7), p.4302-4311

2001

Volltextzugriff (PDF)

Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection

Journal of hepatology, 2022-08, Vol.77 (2), p.525-538

2022

Volltextzugriff (PDF)

A once-per-week or every-two-week dosing regimen is more efficacious for the TIR7 agonist JNJ-64794964 (JNJ-4964) to induce an anti-hepatitis B virus (HBV) effect and HBV-specific immune responses in AAV-HBV mice

Journal of hepatology, 2020-08, Vol.73, p.S864-S865

2020

Volltextzugriff (PDF)

SAT425 - A once-per-week or every-two-week dosing regimen is more efficacious for the TIR7 agonist JNJ-64794964 (JNJ-4964) to induce an anti-hepatitis B virus (HBV) effect and HBV-specific immune responses in AAV-HBV mice

Journal of hepatology, 2020-08, Vol.73, p.S864-S865

2020

Volltextzugriff (PDF)

PS-076-Antiviral activity of JNJ-4964 (AL-034/TQ-A3334), a selective toll-like receptor 7 agonist, in AAV/HBV mice after oral administration for 12 weeks

Journal of hepatology, 2019-04, Vol.70 (1), p.e49-e50

2019

Volltextzugriff (PDF)

JNJ-64794964 (AL-034/TQ-A3334), a TLR7 agonist, induces sustained anti-HBV activity in AAV/HBV mice via non-cytolytic mechanisms

Antiviral research, 2021-12, Vol.196, p.105196-105196, Article 105196

2021

Volltextzugriff (PDF)

Therapeutic vaccine JNJ-0535 induces a strong HBV-specific T-cell response in healthy adults and a modest response in chronic HBV-infected patients

Journal of hepatology, 2022-07, Vol.77, p.S72-S73

2022

Volltextzugriff (PDF)

A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults

Antiviral therapy, 2023-06, Vol.28 (3), p.13596535231172878-13596535231172878

2023

Volltextzugriff (PDF)

Ly49E expression points toward overlapping, but distinct, natural killer (NK) cell differentiation kinetics and potential of fetal versus adult lymphoid progenitors

Journal of leukocyte biology, 2003-06, Vol.73 (6), p.731-738

2003

Volltextzugriff (PDF)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of oral JNJ-64794964, a TLR-7 agonist, in healthy adults

Antiviral therapy, 2021-05, Vol.26 (3-5), p.58-68

2021

Volltextzugriff (PDF)

Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants

Antiviral therapy, 2023-02, Vol.28 (1), p.13596535231151626

2023

Volltextzugriff (PDF)

"Alternatively Activated" Dendritic Cells Preferentially Secrete IL-10, Expand Foxp3+CD4+ T Cells, and Induce Long-Term Organ Allograft Survival in Combination with CTLA4-Ig

The Journal of immunology (1950), 2006-11, Vol.177 (9), p.5868-5877

2006

Volltextzugriff (PDF)

FRI-198-A Phase, double-blind, randomized, placebo-controlled, first-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of oral JNJ-64794964, a toll-like receptor-7 agonist, in healthy adults

Journal of hepatology, 2019-04, Vol.70 (1), p.e478-e478

2019

Volltextzugriff (PDF)

Plasmacytoid Dendritic Cell Precursors Induce Allogeneic T‐Cell Hyporesponsiveness and Prolong Heart Graft Survival

American journal of transplantation, 2005-08, Vol.5 (8), p.1808-1819

2005

Volltextzugriff (PDF)

Low TLR4 Expression by Liver Dendritic Cells Correlates with Reduced Capacity to Activate Allogeneic T Cells in Response to Endotoxin

The Journal of immunology (1950), 2005-02, Vol.174 (4), p.2037-2045

2005

Volltextzugriff (PDF)

Gene expression of MAGE‐A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non–small cell lung cancer patients

Asia-Pacific journal of clinical oncology, 2017-10, Vol.13 (5), p.e212-e223

2017

Volltextzugriff (PDF)

Developmental and functional defects of thymic and epidermal V gamma 3 cells in IL-15-deficient and IFN regulatory factor-1-deficient mice

The Journal of immunology (1950), 2002-06, Vol.168 (12), p.6486-6493

2002

Volltextzugriff (PDF)

Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes

The Journal of immunology (1950), 2002-04, Vol.168 (7), p.3295-3302

2002

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(140)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(100)
Life Sciences & Biomedicine
(63)
Humans
(43)
Male
(27)
Àrees Temàtiques De La Upc
(26)
Animals
(24)
Female
(23)
Physical Sciences
(21)
Immunology
(20)
Adult
(19)
Technology
(18)
Mice
(17)
Middle Aged
(17)
Informàtica
(14)
Matemàtiques I Estadística
(14)
Mice, Inbred C57bl
(13)
Science & Technology - Other Topics
(13)
Aged
(12)
Biological And Medical Sciences
(12)
Mathematics
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Induction of Ovalbumin-Specific Tolerance by Oral Administration of Lactococcus lactis Secreting Ovalbumin

The Sphingosine‐1‐Phosphate Receptor Agonist FTY720 Modulates Dendritic Cell Trafficking In Vivo

Developmental and Functional Defects of Thymic and Epidermal Vγ3 Cells in IL-15-Deficient and IFN Regulatory Factor-1-Deficient Mice

FRI-380 HBV-specific T cell specificity and functionality can be influenced by stage of chronic HBV disease, antigen levels and age

Expression of Inhibitory Receptors Ly49E and CD94/NKG2 on Fetal Thymic and Adult Epidermal TCR Vγ3 Lymphocytes

Expression of Ly49E and CD94/NKG2 on Fetal and Adult NK Cells

Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection

OS-033 A phase 2 open-label study to evaluate safety, tolerability, efficacy, and pharmacodynamics of JNJ-73763989, nucleos (t)ide analogs, and a low-dose PD-1 inhibitor in patients with chronic hepatitis B-Interim results of the OCTOPUS-1 study

LBP-005 Efficacy, safety, tolerability, and immunogenicity of JNJ-0535 following a reduction of viral antigen levels through administration of siRNA JNJ-3989 in patients with chronic HBeAg negative hepatitis B-interim data of the OSPREY study

A once-per-week or every-two-week dosing regimen is more efficacious for the TIR7 agonist JNJ-64794964 (JNJ-4964) to induce an anti-hepatitis B virus (HBV) effect and HBV-specific immune responses in AAV-HBV mice

SAT425 - A once-per-week or every-two-week dosing regimen is more efficacious for the TIR7 agonist JNJ-64794964 (JNJ-4964) to induce an anti-hepatitis B virus (HBV) effect and HBV-specific immune responses in AAV-HBV mice

PS-076-Antiviral activity of JNJ-4964 (AL-034/TQ-A3334), a selective toll-like receptor 7 agonist, in AAV/HBV mice after oral administration for 12 weeks

JNJ-64794964 (AL-034/TQ-A3334), a TLR7 agonist, induces sustained anti-HBV activity in AAV/HBV mice via non-cytolytic mechanisms

Therapeutic vaccine JNJ-0535 induces a strong HBV-specific T-cell response in healthy adults and a modest response in chronic HBV-infected patients

A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults

Ly49E expression points toward overlapping, but distinct, natural killer (NK) cell differentiation kinetics and potential of fetal versus adult lymphoid progenitors

Safety, tolerability, pharmacokinetics, and pharmacodynamics of oral JNJ-64794964, a TLR-7 agonist, in healthy adults

Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants

"Alternatively Activated" Dendritic Cells Preferentially Secrete IL-10, Expand Foxp3+CD4+ T Cells, and Induce Long-Term Organ Allograft Survival in Combination with CTLA4-Ig

FRI-198-A Phase, double-blind, randomized, placebo-controlled, first-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of oral JNJ-64794964, a toll-like receptor-7 agonist, in healthy adults

Plasmacytoid Dendritic Cell Precursors Induce Allogeneic T‐Cell Hyporesponsiveness and Prolong Heart Graft Survival

Low TLR4 Expression by Liver Dendritic Cells Correlates with Reduced Capacity to Activate Allogeneic T Cells in Response to Endotoxin

Gene expression of MAGE‐A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non–small cell lung cancer patients

Developmental and functional defects of thymic and epidermal V gamma 3 cells in IL-15-deficient and IFN regulatory factor-1-deficient mice

Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes

Suchergebnisse filtern